Mersana Therapeutics completes initial public offering
Mersana Therapeutics announced pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share for gross proceeds of $75,000,000. Mersana granted underwriters a 30-day option to purchase up to 750,000 additional shares of its common stock. June 28, 2017